Batch recordBatch (production) record
A batch record is the per-lot proof that a specific batch was made exactly to its approved master recipe, capturing materials, equipment, people, checks, deviations, labels, approvals, and timestamps so regulators can reconstruct events years later.
How does Batch record apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What is a batch record and why it matters
A batch record is the authoritative dossier that demonstrates one batch was manufactured in accordance with the approved master. It is not a summary or a worksheet. It is the legally relied upon narrative of who did what, with which materials and tools, under what parameters, and with what results, accompanied by signatures that carry defined meaning and accountability. Regulators evaluate it as the best single-window view of a site’s adherence to current good manufacturing practice.
The batch record’s force rests on its provenance. It must reflect the contemporaneous execution of the approved master, with any change controlled and justified, not a reconstructed or harmonized afterthought. When the master is revised, the batch record generated for a specific work order must trace to the exact master snapshot in force at start, or to an approved deviation granting a narrowly scoped exception.
The “master-to-batch” contract is explicit in multiple regimes. Dietary supplement manufacturers build the batch record directly from the Master Manufacturing Record elements and any site-level clarifications specified in mmr-111-210. In European pharmaceutical practice, the Qualified Person attests to conformity by reviewing the batch documentation before certification and release, reflected in expectations around the qualified-person-pharma. For device makers, notified bodies routinely sample batch records during surveillance audits to confirm the design and process controls continue to operate as certified, a practice tied to the oversight role of the notified-body.
02Regulatory architecture and terminology
Different statutes and standards use different terms for essentially the same construct. U.S. drug manufacturers prepare a Batch Production or Batch Manufacturing Record under 21 CFR 211.188. Dietary supplement manufacturers prepare a Batch Production Record under 21 CFR 111.255. Medical device manufacturers maintain a Device History Record under 21 CFR 820.184, a requirement transitioning to the Quality Management System Regulation (QMSR), which incorporates ISO 13485 by reference and will be codified at §820.10. Human food facilities document batch production records associated with preventive controls under 21 CFR 117.190. EU GMP Part I, Chapter 4 describes batch processing and packaging records with substantially aligned expectations.
Though terms differ, inspectors consistently expect the record to be attributable, legible, contemporaneous, original, and accurate, with traceability to all inputs and controls, and sufficient detail to reconstruct the batch years later. The EU, PIC/S, and WHO guidance converge on the same essentials: show the lineage of materials, demonstrate the state of equipment, capture each critical parameter and in-process control, and record every signature and timestamp under a controlled system clock.
For harmonization, practitioners map their internal templates to the controlling clauses in their regime. For example, many manufacturers align their templates with 21 CFR 211.188 checklists, mirror EU GMP Chapter 4 sections for process and packaging, and ensure device DHRs cross-reference the Device Master Record and acceptance activities. Under the QMSR’s ISO 13485 alignment, device documentation emphasis shifts to ensuring records demonstrate conformity to specified requirements, but the content necessary to reconstruct the batch remains practically unchanged.
Where firms operate under multiple regimes, a single integrated template is achievable by designing the record to satisfy the most stringent elements among drug, device, and food expectations. This avoids parallel paperwork and supports consistent training and inspection readiness across product families and geographies.
03Scope and applicability across products and operations
A batch record applies whenever a defined quantity of product is manufactured as a discrete lot or batch under a master instruction, whether the process is manual, semi-automated, or fully automated. It covers drug products and APIs, medical devices and combination products, dietary supplements, human food, and veterinary or animal food when manufactured under cGMP or preventive controls. It also applies to packaging and labeling operations that create a distinct batch identity, even when no formulation steps occur.
In continuous or campaign manufacturing, firms still define a batch by time window or quantity to enable traceability and yield calculation. Split batches, reprocessing, and rework must be clearly identified so that parent-to-child and child-to-parent relationships can be traced without ambiguity. Contract and toll manufacturers must ensure the record demonstrates compliance to the sponsor’s master and change controls, with clear demarcation of responsibilities for materials, testing, and release.
Animal food producers operating under preventive controls requirements manage batch documentation that demonstrates hazard analysis and control verification, aligning with process and sanitation records that tie to risk-based parameters. Where site utilities or environmental conditions are critical to quality, readings and alarms relevant to the batch are part of the record, even when captured automatically.
Facilities operating under multiple authorities maintain a harmonized set of batch expectations and apply local addenda only where strictly necessary, to avoid duplicative capture and divergent training. The overarching test remains whether a third-party inspector could reconstruct the batch and determine conformance from the record alone, without relying on institutional memory.
Preventive controls for animal food are codified separately from drug and supplement GMPs but still expect per-lot documentation of key parameters and monitoring results. Responsibilities between brand owners and contract manufacturers must be explicit in the governing quality agreement and visible in the record, as clarified in many inspectional observations involving shared operations under tolling arrangements.
Preventive controls facilities refer to the animal food cGMP and PC requirements for record content and retention, ensuring the batch dossier aligns with hazard controls and verification steps. Where tolling is used, responsibilities for master recipes, deviations, testing, and release must be documented and visible in the batch record to prevent gaps.
Preventive controls expectations for animal food map closely to the general principles outlined in food GMPs, with added emphasis on hazard analysis and preventive controls verification as part of the batch dossier.
Animal food cGMP and preventive controls require batch documentation proportional to risk, but the core elements of materials, equipment, process parameters, checks, deviations, labels, approvals, and retention remain consistent across sectors.
04The twelve mandatory elements every batch record must capture
Across regimes, the content can be expressed as twelve elements that together allow complete reconstruction. First, lot identity: the batch number, product code, strength or version, and unique identifiers that tie to labeling and distribution. Second, master reference: the exact master version or snapshot in force, including any approved deviations or temporary instructions. Third, materials: every component lot received and dispensed, including identity confirmation, quantities, and reconciliations to limits.
Fourth, equipment and utilities: identification of each line, unit, and tool used, with status at use (clean, calibrated, fit for purpose) and any relevant utility parameters. Fifth, process execution: the chronological record of each step, parameters achieved, setpoints and tolerances, and documented holds or restarts. Sixth, in-process controls: checks performed during manufacture and packaging, methods, frequencies, limits, and actual results. Seventh, sampling and testing: samples drawn, test methods, specifications, and data supporting accept or reject decisions, including out-of-specification investigations where applicable.
Eighth, yield and reconciliation: theoretical, actual, and acceptable range, with explanations for variances and a check of printed items and labels issued versus used and destroyed. Ninth, data and attachments: instrument printouts, system reports, and electronic data files referenced in the record, controlled as original data. Tenth, deviations and changes: descriptions, root cause and impact assessments, and dispositions with cross-references to CAPA or change controls where required.
Eleventh, personnel and oversight: operators, verifiers, and supervisors who performed and reviewed each step, with signatures whose meaning is explicitly defined in a signature-meaning-statement. Twelfth, approvals and release: quality review conclusions, release or rejection decisions, and any conditions placed on release, supported by the full record and, where needed, documented in-process-check re-verifications or rework decisions. When these elements are complete, attributable, and contemporaneous, the record will support inspection, certification, and litigation withstand.
05Executing the batch record in practice
Practical execution begins with a controlled work order that captures the master snapshot and authorizes manufacturing. Dispensing and identification checks occur under line clearance and weigh-room controls. Each operator records actions at the time they occur, and reviewers verify completeness and conformance as the batch progresses. Equipment status and cleaning confirmations are documented before use and whenever the line is changed over or paused.
Weights and measures require accuracy and traceability, with tare established and net quantities verified within tolerance. Critical parameters such as temperature, pressure, mixing speed, or dwell time are recorded with sufficient granularity to show control. Where automated systems collect data, the batch record references the originating system and stores or links the original data so that it remains available for review during release and inspection.
In-process controls are documented contemporaneously, and results outside predefined limits trigger immediate hold, investigation, and documented disposition. Label control and reconciliation are treated as a distinct activity, particularly in packaging lines where mislabeling is a leading cause of recalls. At closeout, yield is confirmed against acceptable ranges, all deviations are resolved, and quality review consolidates evidence needed for release.
Training and role assignment underpin reliable execution. Only qualified personnel perform and verify critical steps, and their signatures attest to the meaning defined by site policy. Supervisory review ensures that timing makes sense, that any unusual sequence is explained, and that the overall narrative is coherent for an external reader with no prior context.
06Paper-to-electronic transition under Part 11 and Annex 11
Transitioning from paper to electronic batch records brings clarity and efficiency but also explicit compliance obligations. U.S. and EU regulators expect electronic records and signatures to be trustworthy, reliable, and equivalent to paper with handwritten signatures. This requires validated systems, enforced user access controls, secure audit trails, time-synchronization with a trusted clock, and controls to ensure entries are attributable and contemporaneous.
Audit trails must capture who did what and when, including creation, modification, and deletion events for both metadata and content. Reviewers must regularly assess audit trails as part of release and periodic review. Electronic signatures must bind identity, intent, and meaning, with authentication controls proportionate to risk and segregation of duties that prevents one person from both performing and approving the same critical activity.
Electronic data generated by instruments or automation must be retained in original form or in an acceptable true copy that preserves content and meaning. Where hybrid records are used, the integration points must be robust, with checks that prevent orphaned data or silent overwrites. Firms migrating from paper should pilot critical workflows, qualify infrastructure, and demonstrate that reviewers can navigate, query, and reconstruct the batch without resorting to uncontrolled exports.
07Review and release: the dual-signature model
Two complementary activities govern batch disposition: technical review of manufacturing and quality evaluation of testing and deviations. Drug cGMP provisions emphasize thorough review of all production and control records before release, ensuring that every deviation has been investigated and resolved, that yields and reconciliations are within limits, and that specifications are met by validated methods. Device and food regimes require analogous documented acceptance activities and verification that process and preventive controls were executed and recorded.
A robust model separates performance from approval. The person who performs a step should not be the one who approves it for release. In higher-risk contexts, an additional independent verification layer may be appropriate for identity checks, component dispensing, and critical process parameters. Electronic systems can enforce this separation by workflow, requiring distinct logins and preventing self-approval on restricted steps.
When a batch is partially released, the record must make conditions explicit, document the rationale, and identify the affected units or sublots. If a hold is applied, the basis and required actions must be clear, with traceability to distribution and inventory status. Review-by-exception can increase speed when configured properly, but it depends on well-tuned rules, complete data capture, and vigilant monitoring to ensure no critical signal is bypassed.
Release authorization remains a quality responsibility, and the approver must be able to explain how the record demonstrates conformance. Where a Qualified Person or third-party certification is required, the record must be complete and navigable, with evidence organized to match the authority’s expectations for certification or surveillance audit sampling.
08Retention and reconstruction expectations
Retention policies must match the most conservative requirement applicable to the product and market. The test is not only how long to keep the record, but whether the record will remain readable, retrievable, and complete for the full period. That includes linked electronic data, not just a human-readable summary. In practice, this means format migration planning, system availability controls, and ensured access to the supporting data structures that underpin calculated results or rendered views.
Retention periods are often anchored to the product’s expiry or expected life, plus a minimum number of years. Where products do not carry expiry dating, the trigger shifts to the date of distribution or manufacture. When multiple jurisdictions are served, firms adopt a harmonized retention matrix that defaults to the longest applicable period across regimes and product families. Contract manufacturers should ensure quality agreements align with site policy and the sponsor’s obligations.
Reconstruction expectations include the ability to retrieve the exact master snapshot, every material and instrument record referenced, and a complete audit trail of relevant changes. If a legacy system is retired, true copies and metadata must continue to support meaning. Indexing and search should allow an inspector to navigate from batch number to underlying evidence in minutes, not days.
| Regime | Typical retention trigger | Minimum period (illustrative) | Notes |
|---|---|---|---|
| Drugs (21 CFR 211) | 1 year after expiry | At least 1 year post-expiry | Longer periods common; APIs may follow different standards |
| Medical devices (21 CFR 820/QMSR) | Life of device | Design-specified life | If no life is specified, defined by policy consistent with risk |
| Dietary supplements (21 CFR 111) | 1 year after expiry or distribution | At least 1 year after expiry or 2 years after distribution | Vary by firm policy and shelf-life practices |
| Human food (21 CFR 117) | From date made or distributed | As needed to demonstrate preventive controls | Often several years per program requirements |
| EU GMP | After batch certification/expiry | Post-expiry per EU rules | QP certification drives documentation completeness expectations |
09Common 483 patterns and misinterpretations
Inspectional observations around batch documentation are remarkably consistent. Most do not arise from an exotic interpretation of a clause, but from basic failures of execution and oversight. A recurring theme is the disconnect between what the master specifies and what the operators actually record, either because instructions are unclear or because the record layout does not match the way work is performed.
Another prevalent issue is timeliness. Retrospective entries, undated corrections, and missing initials erode the credibility of the entire dossier. Equally damaging are ambiguous signatures, undefined limits, and yield reconciliations that appear perfunctory or mathematically inconsistent. Where electronic systems are in use, absent or inadequate audit trail review frequently appears in finding narratives.
Firms that avoid these pitfalls do so by making the expected flow of work explicit in the master, configuring records to capture evidence naturally at the point of performance, training operators to understand why entries matter, and auditing the narrative quality of batch records as seriously as they audit content. The aim is a record that reads coherently to an external reviewer who lacks local shorthand or tribal knowledge.
- Incomplete material traceability, especially for rework, returns, or line re-feeds
- Process parameters recorded outside limits without documented impact assessment
- Missing or late in-process checks, or checks recorded without evidence of performance
- Label issuance and reconciliation errors that do not tie to printed inventory
- Yield calculations that omit scrap, rework, or do not match physical counts
- Deviations closed without root cause or without cross-reference to CAPA or change control
- Ambiguous signatures or undefined meaning and authority for approvals
- No audit trail review or inadequate review of electronic changes affecting disposition
10How the batch record relates to neighboring frameworks
The batch record is not an island. It is the execution trace of the quality system’s controls and therefore intersects with document control, training, change control, deviations and CAPA, equipment maintenance, calibration, supplier qualification, labeling, and distribution traceability. Each of these frameworks provides upstream definition or downstream consequence for what is captured in the batch.
Document control governs the master on which the batch record is based. Training ensures operators understand both the steps and their significance. Change control and CAPA shape deviations and corrective actions when an unexpected event occurs. Calibration, maintenance, and cleaning records establish that equipment was fit for use at the time of production, while laboratory controls and method validation ensure that test results used for disposition are scientifically valid.
Supplier qualification underpins the integrity of components and packaging materials, and it should be visible in the batch record via component identity checks and certificates of analysis where appropriate. Label control connects the batch to market identity and to postmarket surveillance through serial numbers or GS1 identifiers. Finally, distribution and complaint systems rely on batch identifiers to enable recalls, field alerts, or trend analysis, linking postmarket signals back to the conditions of manufacture documented in the record.
Because of these interfaces, inspection narratives often traverse from the batch record to the enabling procedures and systems that generated or verified the entries. Designing the batch record with these touchpoints in mind, and making the evidence navigable, reduces time to release and increases confidence during oversight.
11How V5 Ultimate supports batch-record implementation
V5 Ultimate treats the batch record as a contemporaneous artifact generated automatically from the approved master snapshot attached to the work order. Operators execute guided steps at the point of work, while the system captures materials, equipment status, parameters, in-process checks, labels, and yields in structured data. Supervisors and quality reviewers see the same live dossier, with role-based controls that enforce segregation of duties and prevent self-approval of critical steps.
Electronic signatures bind identity, intent, and meaning, and the audit trail records creation, change, and review across the lifecycle. Integrated weighing and labeling, device and sensor interfaces, and laboratory data capture eliminate transcription and reconcile yields and label issuance automatically. Review-by-exception rules highlight only material signals while preserving the full narrative for complete review when needed.
At closeout, V5 compiles a human-readable dossier with links to original electronic records, ensuring retrieval and reconstruction long after distribution. Retention policies, time synchronization, and backup strategies align with regulatory expectations. Whether releasing a drug lot, certifying a batch in Europe, or demonstrating preventive controls for food, the same coherent record supports a defensible, auditable decision.
Frequently asked questions
Q.What is a batch record?+
It is the per-lot dossier that proves a specific batch was made exactly to its approved master, capturing materials, equipment, parameters, checks, deviations, labels, signatures, and timestamps in a form that supports inspection and release.
Q.How is a batch record different from the master record?+
The master defines what must be done and controlled, while the batch record documents what actually happened for a specific lot. Inspectors and release authorities compare the two to confirm conformance and understand any justified deviations.
Q.What must a compliant batch record include?+
It must include lot identity, the master reference, materials and equipment used, process steps and parameters achieved, in-process and laboratory results, deviations and their dispositions, label issuance and reconciliation, yield, signatures, and approvals.
Q.How long should batch records be retained?+
Retention depends on the regime and product type, commonly at least one year past expiry for drugs, the life of the device for medical devices, and for food, long enough to demonstrate preventive controls and support traceability.
Q.Are electronic batch records acceptable to regulators?+
Yes, if the system is validated and complies with electronic record and signature controls, including secure audit trails, user access control, time synchronization, and signatures that bind identity, intent, and meaning.
Q.Who approves a batch for release?+
Quality approves release after thorough review. In the EU, a Qualified Person certifies medicinal product batches before release. In all regimes, approvals must be independent of performance of critical steps and supported by complete documentation.
Primary sources
Further reading
- Electronic Batch Record (EBR)What an EBR must control and how inspectors evaluate equivalence to paper.
- 21 CFR Part 11Electronic records and signatures requirements for trustworthiness and reliability.
- EU GMP Annex 11Expectations for computerized systems supporting GMP records.
- MMR Elements (21 CFR 111.205)The master recipe elements that drive the batch production record.
- 21 CFR 211Drug cGMP requirements including production and control records.
- 21 CFR 820 / QMSRDevice quality system requirements including the Device History Record.
- 21 CFR 117Human food cGMP and preventive controls, including required records.
- BPR Elements (21 CFR 111.255)Specific dietary supplement batch production record content.
- Electronic Batch Record, ExplainedA practical walkthrough of EBR architecture, validation, and review.
- Part 11 Readiness GuideHow to plan, qualify, and maintain compliant electronic record systems.
Explore this topic
Batch record sits inside this topic cluster in our glossary. Every neighbour is one click away.
Master and executed records that prove a batch or device was made to spec.
V5 Ultimate ships with the Batch record controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.
